Abacus Health Products Inc.

Abacus Health Products in its acquisition by Charlotte’s Web

Client

Abacus Health Products Inc.

Value

$99 million

Service

Mergers and Acquisitions

Date Closed

Industry

Health

Lead Office

Montréal


 

On March 23, 2020, Abacus Health Products and Charlotte’s Web Holdings entered into a definitive arrangement agreement whereby Charlotte’s Web will acquire all issued and outstanding subordinate voting shares of Abacus for a total equity consideration of approximately $99 million. The acquisition will combine the resources of Charlotte’s Web and Abacus to create the world’s largest vertically integrated hemp-derived CBD company. The transaction will provide Abacus with the advantages of joining an established platform and benefit from a low cost vertical supply chain.  

Abacus Health Products is specialized in over the counter topical medications combining active pharmaceutical ingredients with hemp extract.

Charlotte’s Web Holdings is focused on producing and distributing innovative hemp-derived CBD wellness products.

Osler, Hoskin & Harcourt LLP advised Abacus with a team consisting of Eric Levy, Bastien Gauthier, Jean-Philippe Bertrand, Erick Lauzière, Jordana Corber-Tovel (Corporate), Jason Comerford (US Corporate), Manon Thivierge (Tax) and Kevin Colan (US Tax).


Team
Eric M. Levy
Key Contact

Eric M. Levy

Partner, Corporate

Bastien  Gauthier

Bastien Gauthier

Partner, Corporate

Jason  Comerford

Jason Comerford

Partner, Corporate

Jean-Philippe Bertrand

Jean-Philippe Bertrand

Associate, Corporate

Erick Lauzière

Erick Lauzière

Associate, Corporate

Jordana Corber-Tovel

Jordana Corber-Tovel

Associate, Corporate

Manon Thivierge

Manon Thivierge

Partner, Taxation

Kevin Colan

Kevin Colan

Counsel, Taxation